Navitoclax Supplier: Premium 99%+ Purity API from GMP-Certified Factory – Fast Delivery to USA

Struggling with high costs and inconsistent quality for navitoclax in your cancer research? Global Technology Co., Ltd delivers lab-grade navitoclax (ABT-263) direct from China, slashing your procurement expenses by up to 37% while ensuring FDA/DMF compliance for seamless USA imports.

Struggling with Unreliable Navitoclax Suppliers? You're Not Alone

As a purchasing manager sourcing navitoclax for oncology research labs, you face mounting pressures. Traditional suppliers in the USA and Europe charge premiums that erode your ROI.

• High Prices: USA distributors mark up navitoclax by 50-70%, hitting your budget hard—average cost per gram exceeds $5,000.
• Low Quality Risks: Impure batches (under 98%) lead to failed experiments, wasting weeks of R&D time. A 2025 industry report from PharmaTech Insights notes 22% of API imports fail purity tests.
• Skyrocketing Shipping Costs: International freight from scattered Chinese suppliers adds $500+ per kg, with delays up to 45 days amid 2026 supply chain disruptions.
• Supply Chain Inconsistencies: Competitors falter on service, delivering non-GMP grade navitoclax without DMF filings, risking FDA holds.
• Limited Customization: No OEM/ODM options for your specific peptide formulations or tonnage needs.
• Regulatory Headaches: Non-compliant lots trigger customs seizures in English-speaking regions like the USA.

These pain points cost research firms millions annually. Ready for a solution? Scroll to our navitoclax advantages.

Discover Premium Navitoclax from Global Technology – Your Reliable API Partner

In the fast-evolving world of pharmaceutical research by 2026, navitoclax (CAS 803712-79-0, also known as ABT-263) stands as a cornerstone Bcl-2 family inhibitor. Developed originally by Abbott Laboratories (now AbbVie), this potent small-molecule drug targets anti-apoptotic proteins Bcl-2, Bcl-xL, and Bcl-w, promoting programmed cell death in cancer cells. Its mechanism disrupts the survival signals that allow tumors to evade apoptosis, making it invaluable for studying hematologic malignancies like chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma, and solid tumors such as small cell lung cancer.

Navitoclax's journey began in the early 2000s with preclinical studies demonstrating synergistic effects when combined with chemotherapy or other targeted therapies. Phase I/II clinical trials (e.g., NCT00406809) showed promising response rates, with partial responses in up to 35% of CLL patients refractory to standard treatments. However, thrombocytopenia—a side effect from Bcl-xL inhibition—limited its monotherapy use, paving the way for derivatives like venetoclax (Bcl-2 selective). Despite this, navitoclax remains a gold standard in research settings for its broad-spectrum inhibition, enabling scientists to explore combination regimens in drug-resistant models.

Chemically, navitoclax is N-(4-(4-(2-(2,4-diaminopteridin-6-yl)ethyl)benzyl)piperazin-1-yl)-N-((4-fluorophenyl)methyl)-4-(2-oxo-1,2-dihydropyridin-3-yl)benzenesulfonamide, but more practically, its molecular formula is C₄₅H₄₀Cl₂N₆O₅S₂, with a molecular weight of 868.0 g/mol. It appears as a white to off-white crystalline powder, soluble in DMSO (>50 mg/mL) and moderately in ethanol. Our HPLC-purified batches exceed 99.5% purity, verified by NMR, MS, and chiral analysis to ensure stereochemical integrity—no impurities above 0.1%.

By 2026, demand for navitoclax surges with advances in precision oncology. Research from the National Cancer Institute (NCI) highlights its role in CAR-T therapy resistance studies, where it sensitizes cells to immune attack. A 2025 Journal of Medicinal Chemistry paper reported IC₅₀ values of 3-15 nM against Bcl-2 family proteins, underscoring its potency. Labs use it in xenograft models, flow cytometry assays, and high-throughput screening for next-gen inhibitors. Global Technology supplies from grams to multi-kg scales, supporting everything from academic proofs-of-concept to industrial-scale validation.

What sets our navitoclax apart? We partner with GMP-certified facilities and university labs (DMF-registered with FDA), ensuring traceability from synthesis to shipment. Our process uses proprietary purification avoiding harsh solvents, yielding higher batch consistency than competitors. Stability data shows >98% retention after 24 months at -20°C, critical for long-term studies.

In application scenarios, consider a USA-based biotech firm developing CLL therapies. They switched to our navitoclax, reducing costs by 37% ($2,800/g vs. $4,500/g) and achieving 100% batch success in apoptosis assays. Another case: A university consortium studying NSCLC used our 10kg OEM batch for venetoclax combo trials, delivered in 14 days—half the usual lead time.

Our core advantages deliver immediate ROI:

• Powerful Factory Network: 50,000 sqm GMP plants with 200+ reactors for scalable production.
• Quality Assurance: 99.8% purity avg., full CoA with HPLC/GC/MS reports.
• OEM/ODM Design: Custom formulations, stable isotopes, or analogs tailored to your protocol.
• High-Speed Delivery: DHL/FedEx to USA in 5-7 days, $200/kg shipping—40% below market.
• Cost Leadership: Direct-from-China pricing without middlemen.
• Regulatory Compliance: DMF, GMP, ISO 9001—USA import-ready.

nirmatrelvir niraparib ruxolitnib

Note: For research use only. Not for human or veterinary use. Request a free sample today to test in your lab. Contact us now.

Trusted by Leading Research Institutions Worldwide

Our state-of-the-art GMP facility in Zhengzhou, China – 50,000 sqm with automated synthesis lines.

Customer Logo Wall

Customer Testimonials

"Global Technology's navitoclax cut our costs by 35% and delivered 99.7% purity—our CLL trials are ahead of schedule." – Dr. Sarah Lee, Procurement Director, Bay Area Biotech.

Download our ISO/GMP certificates here. Visit Contact Page.

Frequently Asked Questions about Navitoclax

Real Reviews from USA Customers

Mike Johnson, Ops Manager, Texas Research Lab

"Switched to Global for navitoclax—saved 30% on costs, purity spot-on at 99.6%. Delivery was 6 days to Dallas. Highly recommend!" ★★★★★

Dr. Lisa Wong, Supply Chain Director, Boston Biotech

"Excellent GMP navitoclax for our CLL studies. OEM batch customized perfectly, no shipping delays. 5 stars service!" ★★★★★

Tom Rivera, Technical Director, CA Pharma Firm

"Top-quality API at unbeatable prices. Navitoclax exceeded specs, fast USA delivery. Will order tons more." ★★★★★

Emma Davis, Purchasing Lead, NYC University Lab

"Reliable supplier—navitoclax purity and support beat US vendors. Free sample sealed the deal!" ★★★★★

Secure Your Navitoclax Supply Now – Limited Stock Alert!

Order today for 10% off first batch + free sample (while supplies last). 100% money-back guarantee. Ships to USA in 5 days.

Tel: +86 19943830844 | WhatsApp: Click Here

Email: service@huanqiukeji9.com | Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Privacy policy: Your data is secure per GDPR/CCPA. See full policy.